SCHEMBL31283508

SCHEMBL31283508

CC(C)(C)OC(=O)n1ccc2c1C(=O)NC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BUB1 O43683 1/20 0.44
GPR119 Q8TDV5 3/20 0.39
MAPK1 P28482 1/20 0.39
BCHE P06276 1/20 0.35
ESR2 Q92731 1/20 0.34
KDM4E B2RXH2 2/20 0.33
NR1H2 P55055 2/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
DDB1 Q16531 2/20 0.33
CRBN Q96SW2 2/20 0.33
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
POLB P06746 1/20 0.32
PARP1 P09874 1/20 0.32
TNKS2 Q9H2K2 1/20 0.32
PARP2 Q9UGN5 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
JAK2 O60674 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5331753 0.71 AURKA (0.42) BUB1GPR119MAPK1HSP90AA1HSP90AB1
SCHEMBL28276822 0.70 BUB1 (0.46) BUB1MAPK1BCHEESR2NR1H2
SCHEMBL20780061 0.69 BUB1 (0.50) BUB1GPR119MAPK1BCHEESR2
SCHEMBL27126011 0.68 BUB1 (0.46) BUB1BCHEKDM4EMAPTTHRB
SCHEMBL29163695 0.68 BUB1 (0.52) BUB1MAPK1BCHEESR2DDB1
SCHEMBL15829073 0.66 BUB1 (0.47) BUB1GPR119MAPK1BCHEESR2
SCHEMBL31630952 0.65 BUB1 (0.46) BUB1GPR119BCHEKDM4ENR1H2
SCHEMBL29001229 0.65 BUB1 (0.46) BUB1GPR119BCHEESR2KDM4E
SCHEMBL3216325 0.65 BUB1 (0.40) BUB1GPR119MAPK1BCHEESR2
SCHEMBL2909152 0.65 BUB1 (0.40) BUB1GPR119MAPK1BCHEESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4739393-A1 TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS Merck Sharp & Dohme LLC (US) 2026-05-13 EP disclosed
US-20250026759-A1 TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS MERCK SHARP & DOHME LLC (US) 2025-01-23 US disclosed
WO-2025014788-A1 TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS MERCK SHARP & DOHME LLC (US) 2025-01-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250026759-A1 TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS ACIN1, REV1, NFATC1 BUB1 1572/4885GPR119 4041/4885MAPK1 860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.